First Header Logo Second Header Logo

Connection

Joseph Yeboah to Hypoglycemic Agents

This is a "connection" page, showing publications Joseph Yeboah has written about Hypoglycemic Agents.
Connection Strength

0.150
  1. Branch M, German C, Bertoni A, Yeboah J. Incremental risk of cardiovascular disease and/or chronic kidney disease for future ASCVD and mortality in patients with type 2 diabetes mellitus: ACCORD trial. J Diabetes Complications. 2019 07; 33(7):468-472.
    View in: PubMed
    Score: 0.150
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.